Theragent Secures Novel Stem Cell Bank Production Contract with Accelerated Biosciences

ARCADIA, Calif., Jan. 12, 2023 /PRNewswire/ -- Theragent, a cell therapy Contract Development and Manufacturing Organization (CDMO) focused on advancing next-generation cancer and rare disease treatments, has announced an agreement with Accelerated Biosciences, a regenerative medicine...

Click to view original post